Alopecia Areata
📧 Sign up to get email alerts when something new happens for Alopecia Areata.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-01-12Clinical Trial Update: A Study of LAD603 in Adults With Alopecia Areata [Phase 2]
Phase 2 clinical trial update for LAD603 in adults with alopecia areata; the study is currently recruiting.
-
CLINICAL_TRIALS research · 2025-12-24Clinical Trial Update: A Study to Evaluate the Safety and Effectiveness of Upadacitinib Tablets in Adult and Adolescent Participants in Japan With Alopecia Areata [Phase 3]
AbbVie is conducting a Phase 3 study in Japan to evaluate the safety and effectiveness of upadacitinib tablets for alopecia areata in adults…
-
CLINICAL_TRIALS research · 2025-12-11Clinical Trial Update: A Study of DR-01 in Subjects With Alopecia Areata and Vitiligo [Phase 1]
Phase 1 clinical trial of DR-01 for alopecia areata and vitiligo is currently recruiting.
-
CLINICAL_TRIALS research · 2025-12-01Clinical Trial Update: Evaluate the Efficacy and Safety of Ruxolitinib on Hair Regrowth in Patients With Autoimmune Polyendocrinopathy Candidiasis Ectodermal Dystrophy (APECED)-Associated Alopecia Areata [Phase 2]
A Phase 2 clinical trial is evaluating the efficacy and safety of ruxolitinib for hair regrowth in patients with Autoimmune Polyendocrinopat…
-
CLINICAL_TRIALS research · 2025-11-24Clinical Trial Update: Comparison of Microneedling Along With Topical Vitamin D3 Versus Microneedling in Alopecia Areata [NA]
Clinical trial evaluating whether adding topical Vitamin D3 to microneedling improves outcomes in alopecia areata compared with microneedlin…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-11-20Clinical Trial Update: A Study to Evaluate the Safety and Efficacy of FB102 in Patients With Severe to Very Severe Alopecia Areata. [Phase 1]
Forte Biosciences is running a Phase 1 study to evaluate the safety and efficacy of FB102 in patients with severe to very severe alopecia ar…
-
CLINICAL_TRIALS research · 2025-11-20Clinical Trial Update: A Study to Learn About Litfulo Capsule in People With Severe Alopecia Areata in Routine Clinical Practice.
Pfizer's Litfulo (deucravacitinib) is listed as recruiting for a study to observe its use in people with severe alopecia areata in routine c…
-
CLINICAL_TRIALS research · 2025-10-31Clinical Trial Update: A Phase 2a Proof-of-Concept Trial of Bempikibart (ADX-914) for the Treatment of Severe Alopecia Areata (SIGNAL-AA) [Phase 2]
A Phase 2a proof-of-concept trial evaluating Bempikibart (ADX-914) for severe Alopecia Areata is ongoing but not recruiting.
-
CLINICAL_TRIALS research · 2025-10-24Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Subcutaneous Amlitelimab Monotherapy Compared With Placebo in Adult Participants With Severe Alopecia Areata [Phase 2]
A Phase 2 study is evaluating subcutaneous amlitelimab as monotherapy versus placebo in adults with severe Alopecia Areata, and the trial is…
-
CLINICAL_TRIALS research · 2025-10-01Clinical Trial Update: A Study of 2 Doses of Ritlecitinib in People 12 Years of Age and Older With Alopecia Areata [Phase 3]
A Phase 3 clinical trial is evaluating two doses of ritlecitinib for alopecia areata in people aged 12 years and older, and the study is cur…
-
CLINICAL_TRIALS research · 2025-10-01Clinical Trial Update: A Long-Term Study to Learn About The Study Medicine Called Ritlecitinib in Children With Severe Alopecia Areata. [Phase 3]
Clinical trial update announcing a Phase 3 long-term study of ritlecitinib in children with severe alopecia areata; recruiting.
-
CLINICAL_TRIALS research · 2025-09-17Clinical Trial Update: A Phase 1 Trial to Evaluate the Safety, Tolerability, Pharmacodynamics, Pharmacokinetics, and Immunogenicity of VIS171 in Participants With Autoimmune Disease(s) [Phase 1]
A Phase 1 clinical trial is evaluating the safety, tolerability, pharmacodynamics, pharmacokinetics, and immunogenicity of VIS171 in partici…
-
CLINICAL_TRIALS research · 2025-09-12Clinical Trial Update: Intralesional Cyclosporine for Alopecia Areata [EARLY_Phase 1]
A clinical trial is evaluating intralesional cyclosporine for alopecia areata in an early Phase 1 study. The study is currently recruiting.
-
CLINICAL_TRIALS research · 2025-09-08Clinical Trial Update: Evaluation of Microbiota Transplant Therapy in Patients With Alopecia Areata [Phase 2]
Phase 2 clinical trial evaluating microbiota transplant therapy for alopecia areata and related conditions is currently recruiting.
-
CLINICAL_TRIALS research · 2025-08-26Clinical Trial Update: Evaluation of Stigma Toward Patients With Alopecia Areata, Atopic Dermatitis, Vitiligo, and Psoriasis
This update describes a clinical trial evaluating stigma toward patients with alopecia areata, atopic dermatitis, vitiligo, and psoriasis, c…
-
CLINICAL_TRIALS research · 2025-07-29Clinical Trial Update: Regeneron AA Multicenter (Dupilumab) [Phase 2]
Regeneron's dupilumab is being studied in a multicenter Phase 2 trial for Alopecia Areata. The study is currently recruiting.
-
CLINICAL_TRIALS research · 2025-07-22Clinical Trial Update: Determinants of Chronic Inflammatory Skin Disease Trajectories
An ongoing clinical study is investigating determinants of chronic inflammatory skin disease trajectories, spanning multiple conditions such…
-
CLINICAL_TRIALS research · 2025-06-03Clinical Trial Update: Study to Evaluate Safety and Efficacy of SYHX1901 Tablets in Severe Alopecia Areata Patients [Phase 2]
Phase 2 trial to evaluate the safety and efficacy of SYHX1901 tablets in severe alopecia areata; the study is not yet recruiting.
-
CLINICAL_TRIALS research · 2025-01-28Clinical Trial Update: Evaluating the Effectiveness and Tolerance of Baricitinib in the Treatment of Acute Alopecia Areata With Active Hair Shedding: A Prospective Open-Label Study [Phase 2]
This is a Phase 2 prospective open-label study evaluating the effectiveness and tolerability of Baricitinib for acute Alopecia Areata with a…
-
CLINICAL_TRIALS research · 2024-12-03Clinical Trial Update: The Epidemiology, Management and Comorbidities in Alopecia Areata in Czech Republic
A Czech Republic clinical study on the epidemiology, management, and comorbidity patterns of alopecia areata has completed.
-
CLINICAL_TRIALS research · 2024-08-27Clinical Trial Update: Efficacy and Safety of JAK Inhibitors in Patients With AA: RWE Study
A real-world evidence study assessing efficacy and safety of JAK inhibitors in patients with Alopecia Areata, currently recruiting.
-
CLINICAL_TRIALS research · 2024-08-21Clinical Trial Update: Clinical Trial on the Efficacy of Intralesional Triamcinolone Versus Candida Albicans Antigen in Treating Alopecia Areata [NA]
This clinical trial is recruiting to compare intralesional triamcinolone versus Candida albicans antigen for Alopecia Areata.
-
CLINICAL_TRIALS research · 2024-08-09Clinical Trial Update: Retinol Binding Protein 4 Protein in Alopecia Areata Treated With Barcitinib [Phase 1]
Phase 1 clinical trial evaluating Barcitinib for alopecia areata; the study is currently active but not recruiting.
-
CLINICAL_TRIALS research · 2024-06-24Clinical Trial Update: Evaluation of the Efficacy of Systemic Treatments for Alopecia (ESTAA)
This document reports a clinical trial update evaluating systemic treatments for alopecia areata; no results or current status are provided.
-
CLINICAL_TRIALS research · 2024-05-06Clinical Trial Update: Topical Simvastatin Versus Topical Steroid in Treatment of Alopecia Areata [Phase 4]
A Phase 4 clinical trial compares topical simvastatin with a topical steroid for alopecia areata, sponsored by Assiut University; the study …